BIOCEUTICALS – Glucofactors 120C

Directions for Use

Adults:
Take 1 capsule daily or as directed by your healthcare practitioner.

Warnings

• If symptoms persist, consult your healthcare practitioner.
• If you have any pre-existing conditions, are on any medications, always talk to your health professional before use.
• Some products should be ceased at least two weeks before any elective surgery, please confirm with your health professional.
• Keep out of reach of children.
• Vitamin supplements should not replace a balanced diet.
• Always read the label. Use only as directed.

Prescribing Information:

• GlucoFactors Forte® is contraindicated in pregnancy. Chromium appears to be safe in pregnancy and lactation, however bitter melon is contraindicated, and Trigonella foenum-graecum has empirical use as an emmenagogue and arbortifacient.
• The use of Gymnema sylvestre and alpha-lipoic acid in lactation has not been scientifically validated.
• Chromium and iron compete for binding sites on transferrin, the iron transport protein. However, doses up to 925mcg of chromium per day have shown no significant effect on iron status.
• One single case report suggests a theoretical interaction between the concomitant use of chromium with insulin in which hypoglycaemia was provoked.
• Caution G. sylvestre with concomitant use of antidiabetic medications. Gymnema has reduced blood glucose in diabetic patients, thereby requiring dosage adjustments of diabetic medication.
• Caution with hypoglycaemic agents; theoretically an additive effect is possible.
• Theoretically, concomitant use of goat’s rue could potentiate hypoglycaemic drug effects.
• Some literature caution that using alpha-lipoic acid with antidiabetic drugs may theoretically cause additive hypoglycaemic effects. However, two randomised, controlled studies show no detectable drug interaction or safety issues with the concomitant intake of alpha-lipoic acid (up to 600mg daily) with glibenclamide, acarbose (Glucobay), metformin, sulfonylureas, troglitazone or insulin.